First Time Loading...

Regulus Therapeutics Inc
NASDAQ:RGLS

Watchlist Manager
Regulus Therapeutics Inc Logo
Regulus Therapeutics Inc
NASDAQ:RGLS
Watchlist
Price: 2.25 USD -7.41%
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

RGLS Price Targets Summary
Regulus Therapeutics Inc

Wall Street analysts forecast RGLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGLS is 6.32 USD with a low forecast of 2.02 USD and a high forecast of 11.55 USD.

RGLS Lowest Forecast
Wall Street Target
2.02 USD
10% Downside
RGLS Average Forecast
Wall Street Target
6.32 USD
181% Upside
RGLS Highest Forecast
Wall Street Target
11.55 USD
413% Upside
Lowest
Price Target
2.02 USD
10% Downside
Average
Price Target
6.32 USD
181% Upside
Highest
Price Target
11.55 USD
413% Upside
Regulus Therapeutics Inc Competitors:
Price Targets
OCGN
Ocugen Inc
257% Upside
300639
Guangdong Hybribio Biotech Co Ltd
509% Upside
C
688276
Changchun BCHT Biotechnology Co
54% Upside
002007
Hualan Biological Engineering Inc
33% Upside
OCGN
Ocugen Inc
257% Upside
300639
Guangdong Hybribio Biotech Co Ltd
509% Upside
C
688276
Changchun BCHT Biotechnology Co
54% Upside
002007
Hualan Biological Engineering Inc
33% Upside
B
002038
Beijing SL Pharmaceutical Co Ltd
384% Upside
MRUS
Merus NV
31% Upside
BONEX
Bonesupport Holding AB
33% Upside
Y
301301
Yili Chuanning Biotechnology Co Ltd
37% Downside

Revenue
Forecast

Revenue Estimate
Regulus Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Regulus Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Regulus Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
What are analyst estimates?

See Also

Summary
RGLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
RGLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RGLS stock valuation using valuation multiples.
Wall Street Estimates
RGLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RGLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGLS's stock price target?
Price Target
6.32 USD

According to Wall Street analysts, the average 1-year price target for RGLS is 6.32 USD with a low forecast of 2.02 USD and a high forecast of 11.55 USD.

ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.